Inhibition of intracranial glioma growth by endometrial regenerative cells

Cell Cycle

Volumn 8, Issue 4, 2009, Pages 606-610

  Han, Xiaodi ^a,b,i   Meng, Xiaolong ^a   Yin, Zhenglian ^a   Rogers, Andrea ^a   Zhong, Jie ^a   Rillema, Paul ^b   Jackson, James A ^a   Ichim, Thomas E ^c   Minev, Boris ^d,e   Carrier, Ewa ^d   Patel, Amit N ^f   Murphy, Michael P ^g   Min, Wei Ping ^h   Riordan, Neil H ^a,c  

^a Bio Communications Research Institute   (United States)

^b WICHITA STATE UNIVERSITY   (United States)

^c Medistem Inc   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cancer stem cells; Endometrial regenerative cells; Glioma; Immune; Mesenchymal stem cells; Stem cell therapy

Indexed keywords

CD133 ANTIGEN;

ADOLESCENT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOMETRIUM CELL; GLIOMA; HUMAN; HUMAN CELL; INTRACRANIAL TUMOR; LIMB ISCHEMIA; MALE; MESENCHYME CELL; NONHUMAN; PLURIPOTENT STEM CELL; RAT; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALIA; RATTUS;

EID: 61449183631     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.4.7731     Document Type: Article

References (35)

1. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97:12846-51.
2. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002; 62:5657-63.
3. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor- related apoptosis-inducing ligand. Cancer Res 2002; 62:7170-4.
4. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65:3307-18.
5. Pisati F, Belicchi M, Acerbi F, Marchesi C, Giussani C, Gavina M, et al. Effect of human skin-derived stem cells on vessel architecture, tumor growth and tumor invasion in brain tumor animal models. Cancer Res 2007; 67:3054-63.
6. Meng X, Ichim TE, Zhong J, Rogers A, Yin Z, Jackson J, et al. Endometrial regenerative cells: a novel stem cell population. J Transl Med 2007; 5:57.
7. Murphy MP, Wang H, Patel AN, Kambhampati S, Angle N, Chan K, et al. Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia? J Transl Med 2008; 6:45.
8. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, et al. HIFlalpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008; 13:206-20.
9. Ahn GO, Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008; 13:193-205.
10. Bexell D, Gunnarsson S, Tormin A, Darabi A, Gisselsson D, Roybon L, et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 2008.
11. Zong ZW, Cheng TM, Su YP, Ran XZ, Shen Y, Li N, et al. Recruitment of transplanted dermal multipotent stem cells to sites of injury in rats with combined radiation and wound injury by interaction of SDF-1 and CXCR4. Radiat Res 2008; 170:444-50.
12. Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, et al. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem Cells 2008; 26:1406-13.
13. Zhang G, Nakamura Y, Wang X, Hu Q, Suggs LJ, Zhang J. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 2007; 13:2063-71.
14. Spevack DM, Cavaleri S, Zolotarev A, Liebes L, Inghirami G, Tunick PA, et al. Increase in circulating bone marrow progenitor cells after myocardial infarction. Coron Artery Dis 2006; 17:345-9.
15. Wang Y, Deng Y, Zhou GQ. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 2008; 1195:104-12.
16. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D, et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol 2004; 63:84-96.
17. Fernandes RS, Kirszberg C, Rumjanek VM, Monteiro RQ. On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells. J Thromb Haemost 2006; 4:1546-52.
18. Tada M, Diserens AC, Desbaillets I, de Tribolet N. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg 1994; 80:1063-73.
19. + progenitors target the inflamed brain and display in vitro differentiation potential toward microglia. FASEB J 2006; 20:2081-92.
20. Postovit LM, Seftor EA, Seftor RE, Hendrix MJ. Influence of the microenvironment on melanoma cell fate determination and phenotype. Cancer Res 2006; 66:7833-6.
21. Qiao L, Xu ZL, Zhao TJ, Ye LH, Zhang XD. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett 2008; 269:67-77.
22. Qiao L, Zhao TJ, Wang FZ, Shan CL, Ye LH, Zhang XD. NFkappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells. Acta Pharmacol Sin 2008; 29:333-40.
23. DeKoter RP, Parsons MF, Fong WG, Lin CH, Khalil W, Howson-Jan K, et al. Suppression of myelopoiesis and myeloid leukemia cell line proliferation by a novel bone marrow- derived factor, reptimed. Cell Immunol 1997; 175:120-7.
24. Zipori D. Conditions required for the inhibition of in vitro growth of a mouse myeloma cell line by adherent bone-marrow cells. Cell Tissue Kinet 1981; 14:479-88.
25. Khandaker MH, Kadhim SA, Ichim TE, Howson-Jan K, Chin J, Singhal SK. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed. Anticancer Res 2000; 20:183-9.
26. Senyukov VV, Seledtsov VI, Poveshchenko OV, Taraban VY, Kozlov VA. Soluble factor and cell-cell interaction in cytostasis induced by bone marrow cells. Bull Exp Biol Med 2000; 129:559-61.
27. Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, Eliceiri BP, Reisfeld RA. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 2002; 8:1369-75.
28. Olivotto M, Dello Sbarba P. Environmental restrictions within tumor ecosystems select for a convergent, hypoxia-resistant phenotype of cancer stem cells. Cell Cycle 2008; 7:176-87.
29. Keith B, Simon MC. Hypoxia-inducible factors, stem cells and cancer. Cell 2007; 129:465-72.
30. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 2008; 45:514-22.
31. Patel AN, Park E, Kuzman M, Benetti F, Silva FJ, Allickson JG. Multipotent menstrual blood stromal stem cells: isolation, characterization and differentiation. Cell Transplant 2008; 17:303-11.
32. Li Y, Bohlen P, Hicklin DJ. Vaccination against angiogenesis-associated antigens: a novel cancer immunotherapy strategy. Curr Mol Med 2003; 3:773-9.
33. Wei YQ, Wang QR, Zhao X, Yang L, Tian L, Lu Y, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med 2000; 6:1160-6.
34. Ferguson TA, Stuart PM, Herndon JM, Griffith TS. Apoptosis, tolerance and regulatory T cells-old wine, new wineskins. Immunol Rev 2003; 193:111-23.
35. Mellor AL, Munn DH. Creating immune privilege: Active local suppression that benefits friends, but protects foes. Nat Rev Immunol 2008; 8:74-80.